Want to see NAUT full AI Analyst Report?
Nautilus Biotechnolgy (NAUT) Income Statement
Nautilus Biotechnolgy Income Statement
Last quarter (Q3 2026), Nautilus Biotechnolgy's total revenue was $234.00K. In Q3, Nautilus Biotechnolgy's net income was $-15.64M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -6.46M | $ -6.35M | $ -5.71M | $ 0.00 | $ -2.84M | |
| $ 60.37M | $ 75.12M | $ 70.45M | $ 63.62M | $ 47.66M | |
| Depreciation and Amortization | $ 6.46M | $ 6.35M | $ 5.71M | $ 3.42M | $ 2.84M |
| $ -52.54M | $ -64.43M | $ -57.97M | $ -60.08M | $ -47.47M | |
| $ -66.84M | $ -81.48M | $ -76.15M | $ -63.62M | $ -50.50M | |
| $ 7.84M | $ 10.70M | $ 12.48M | $ 5.69M | $ 183.00K | |
| $ -59.00M | $ -70.78M | $ -63.67M | $ -57.92M | $ -50.31M | |
| $ -59.00M | $ -70.78M | $ -63.67M | $ -57.92M | $ -50.31M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.47 | $ -0.56 | $ -0.51 | $ -0.46 | $ -0.60 |
| Diluted EPS | $ -0.47 | $ -0.56 | $ -0.51 | $ -0.46 | $ -0.60 |
| Weighted Average Shares Outstanding | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M |
| Weighted Average Shares Outstanding (Diluted) | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M |
Currency in USD